Active ingredientRomidepsinCat. No. P-R083-001CAS 128517-07-7Family · Pharmaceutical analytical standards
Romidepsin
A natural histone deacetylase (HDAC) inhibitor produced by the bacterium Chromobacterium violaceum, first described in 1994 and approved in the United States in 2009 for cutaneous T-cell lymphoma. This family brings together the active ingredient and other impurities.
Did you know?The bacterium was isolated from a soil sample from Yamagata Prefecture, Japan: the molecule turned out to have almost no antibacterial activity but to be highly active against several human cancer cell lines.
Go to the active ingredient →Active ingredientRomidepsinCat. No. P-R083-001CAS 128517-07-7
ImpurityRomidepsin Impurity 1Cat. No. P-R083-003
ImpurityRomidepsin Impurity 2Cat. No. P-R083-004
ImpurityRomidepsin Impurity 3Cat. No. P-R083-005
ImpurityRomidepsin Impurity 4Cat. No. P-R083-006
ImpurityRomidepsin Impurity 5Cat. No. P-R083-007No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.